Jihua Dong Selected Research

Drug Combinations

1/2022

Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jihua Dong Research Topics

Disease

5	Neoplasms (Cancer) 02/2019 - 01/2005
3	Neoplasm Metastasis (Metastasis) 02/2019 - 02/2010
3	Brain Injuries (Brain Injury) 12/2016 - 03/2015
3	Infections 04/2009 - 01/2006
2	Inflammation (Inflammations) 12/2016 - 06/2010
2	Transitional Cell Carcinoma 06/2009 - 01/2005
2	Nasopharyngeal Carcinoma 09/2006 - 01/2006
2	Myocarditis (Carditis) 01/2005 - 04/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2005 - 01/2005
1	COVID-19 01/2022
1	Brain Neoplasms (Brain Tumor) 02/2019
1	Glioblastoma (Glioblastoma Multiforme) 02/2018
1	Stomach Neoplasms (Stomach Cancer) 02/2010
1	Cardiomyopathies (Cardiomyopathy) 08/2008
1	Wounds and Injuries (Trauma) 08/2008
1	Hepatitis 01/2008
1	Carcinoma (Carcinomatosis) 12/2007
1	Convalescence 01/2006
1	Viral Encephalitis 01/2006
1	Necrosis 01/2006
1	Herpes Simplex 01/2006
1	Coronary Disease (Coronary Heart Disease) 04/2003
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2003

Drug/Important Bio-Agent (IBA)

2	Small Interfering RNA (siRNA)IBA 02/2019 - 02/2010
2	RNA (Ribonucleic Acid)IBA 02/2019 - 01/2005
2	Uroplakin IIIBA 06/2009 - 01/2005
2	CytokinesIBA 08/2008 - 01/2006
2	AutoantibodiesIBA 08/2008 - 04/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006 - 01/2005
1	Drug CombinationsIBA 01/2022
1	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 02/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Biological ProductsIBA 02/2018
1	Pharmaceutical PreparationsIBA 02/2018
1	ErbB Receptors (EGF Receptor)IBA 02/2018
1	corilaginIBA 12/2016
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 06/2010
1	heparanaseIBA 02/2010
1	matrigelIBA 02/2010
1	Messenger RNA (mRNA)IBA 06/2009
1	DNA (Deoxyribonucleic Acid)IBA 04/2009
1	Monoclonal AntibodiesIBA 08/2008
1	Immunoglobulin G (IgG)IBA 08/2008
1	ATP Translocases Mitochondrial ADPIBA 08/2008
1	AntibodiesIBA 08/2008
1	Interferon-alpha (Interferon Alfa)IBA 01/2008
1	tanshinoneIBA 12/2007
1	Antineoplastic Agents (Antineoplastics)IBA 12/2007
1	Cytostatic AgentsIBA 12/2007
1	technetium 99m methoxyisobutylisonitrileIBA 09/2006
1	Interleukin-2 (IL2)IBA 01/2006
1	Interleukin-10 (Interleukin 10)IBA 01/2006
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006
1	CurcuminIBA 01/2005
1	LipofectamineIBA 01/2005
1	ProdrugsIBA 01/2005
1	EsterasesIBA 01/2005
1	AutoantigensIBA 04/2003
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 04/2003
1	Cardiac MyosinsIBA 04/2003

Therapy/Procedure

2	Therapeutics 01/2022 - 06/2009
2	Radiotherapy 10/2016 - 03/2015
2	Aftercare (After-Treatment) 01/2006 - 01/2005
1	Cranial Irradiation 12/2016
1	Drug Therapy (Chemotherapy) 01/2005